RAVINDRA B. UPASANI,BOYD, L. HARRISON,BENNY C. JR. ASKEW,JEAN-COSME DODART,FRANCESCO G. SALITURO,ALBERT J. ROBICHAUD
申请号：
HK15100472.0
公开号：
HK1200173A
申请日:
2015.01.15
申请国别(地区):
HK
年份:
2015
代理人:
摘要：
Compounds are provided according to Formula (I) and pharmaceutically acceptable salts thereof, wherein Z is a group of the formula (i), (ii), (iii), (iv), or (v), and wherein L1, L2, L3, X1, X2, Y, Rz4, Rz5, Rz6, n, R1, R2, R3a, R3b, R4a, R4b, R6a, R6b, R7a, R7b, R11a, R11b, R14, R17, R19, R20, R23a, R23b, and R24 are as defined herein, and pharmaceutical compositions thereof. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of CNS-related conditions in mammals.
